Advanced Hormone Sensitive Prostate Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11853 | Relugolix | An oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB11853 | Relugolix | Serum albumin | carrier |
| DB11853 | Relugolix | Alpha-1-acid glycoprotein 1 | carrier |
| DB11853 | Relugolix | P-glycoprotein 1 | transporter |
| DB11853 | Relugolix | ATP-binding cassette sub-family G member 2 | transporter |
| DB11853 | Relugolix | Cytochrome P450 3A Subfamily | enzyme |
| DB11853 | Relugolix | Cytochrome P450 2C8 | enzyme |
| DB11853 | Relugolix | Cytochrome P450 2B6 | enzyme |
| DB11853 | Relugolix | Gonadotropin-releasing hormone receptor | target |